Special Issue “Virus-Like Particle Vaccines”

by Monique Vogel, Martin F. Bachmann
Published 2020-08-01

The Prospects of an Active Vaccine Against Asthma Targeting IL-5

by Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann, Aadil El-Turabi, Antonia Fettelschoss-Gabriel, Antonia Fettelschoss-Gabriel, Monique Vogel, Monique Vogel
Published 2018-10-01

COVID-19: Mechanisms of Vaccination and Immunity

by Daniel E. Speiser, Martin F. Bachmann
Published 2020-07-01

Virus-Specific Secondary Plasma Cells Produce Elevated Levels of High-Avidity Antibodies but Are Functionally Short Lived

by Caroline C. Krueger, Caroline C. Krueger, Franziska Thoms, Elsbeth Keller, Elsbeth Keller, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann
Published 2019-08-01

Harnessing Nanoparticles for Immunomodulation and Vaccines

by Ariane C. Gomes, Mona Mohsen, Martin F. Bachmann
Published 2017-02-01

RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion

by Caroline C. Krueger, Caroline C. Krueger, Franziska Thoms, Elsbeth Keller, Elsbeth Keller, Fabiana M. S. Leoratti, Fabiana M. S. Leoratti, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann
Published 2019-04-01

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2

by Ariane C. Gomes, Mona O. Mohsen, Julius E. Mueller, Fabiana M. S. Leoratti, Gustavo Cabral-Miranda, Martin F. Bachmann, Martin F. Bachmann
Published 2019-08-01

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design

by Ariane C. Gomes, E. S. Roesti, Aadil El-Turabi, Martin F. Bachmann
Published 2019-06-01

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System

by Mona O. Mohsen, Ariane C. Gomes, Monique Vogel, Martin F. Bachmann
Published 2018-07-01

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

by Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser
Published 2021-01-01

On Iron Metabolism and Its Regulation

by Anne-Cathrine S. Vogt, Tasneem Arsiwala, Mona Mohsen, Monique Vogel, Vania Manolova, Martin F. Bachmann
Published 2021-04-01

Bacterially produced recombinant influenza vaccines based on virus-like particles.

by Andrea Jegerlehner, Franziska Zabel, Alice Langer, Klaus Dietmeier, Gary T Jennings, Philippe Saudan, Martin F Bachmann
Published 2013-01-01

Vaccination against GIP for the treatment of obesity.

by Alma Fulurija, Thomas A Lutz, Katja Sladko, Melania Osto, Peter Y Wielinga, Martin F Bachmann, Philippe Saudan
Published 2008-01-01

Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes

by Gunther Spohn, Christian Schori, Iris Keller, Katja Sladko, Christina Sina, Reto Guler, Katrin Schwarz, Pål Johansen, Gary T Jennings, Martin F Bachmann
Published 2014-01-01

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)

by Matthew D. Heath, Matthew D. Heath, Mona O. Mohsen, Mona O. Mohsen, Pieter-Jan de Kam, Thalia L. Carreno Velazquez, Simon J. Hewings, Simon J. Hewings, Matthias F. Kramer, Matthias F. Kramer, Thomas M. Kündig, Martin F. Bachmann, Martin F. Bachmann, Murray A. Skinner, Murray A. Skinner
Published 2020-11-01

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

by Mona O. Mohsen, Mona O. Mohsen, Mona O. Mohsen, Monique Vogel, Carsten Riether, Julius Muller, Silvia Salatino, Nicola Ternette, Ariane C. Gomes, Gustavo Cabral-Miranda, Aadil El-Turabi, Christiane Ruedl, Thomas M. Kundig, Said Dermime, Alexander Knuth, Daniel E. Speiser, Martin F. Bachmann, Martin F. Bachmann
Published 2019-05-01

Versatile virus-like particle carrier for epitope based vaccines.

by Alain C Tissot, Regina Renhofa, Nicole Schmitz, Indulis Cielens, Edwin Meijerink, Velta Ose, Gary T Jennings, Philippe Saudan, Paul Pumpens, Martin F Bachmann
Published 2010-01-01

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

by Xuelan Liu, Xinyue Chang, Dominik Rothen, Mariliza Derveni, Pascal Krenger, Salony Roongta, Edward Wright, Monique Vogel, Kaspars Tars, Mona O. Mohsen, Martin F. Bachmann
Published 2021-04-01

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines

by Darren B. Leneghan, Kazutoyo Miura, Iona J. Taylor, Yuanyuan Li, Jing Jin, Karl D. Brune, Martin F. Bachmann, Mark Howarth, Carole A. Long, Sumi Biswas
Published 2017-06-01

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus

by Elisa S. Roesti, Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel, Martin F. Bachmann
Published 2020-03-01